Albemarle Corporation

    Jurisdiction
    United States
    LEI
    HDBLS2Q6GV1LSKQPBS54
    ISIN
    US0126531013 (ALB)
    Sectors
    1. Basic Materials
    2. Chemicals - Specialty

    Scores

    InsiderPie Expert Score
    52 / 100
    Even with peer group:
    52 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Read full profile

    Fundamentals

    Net revenue
    €4.26B
    Gross margin
    7.8%
    EBIT
    -€884.63M
    EBIT margin
    -20.8%
    Net income
    -€792.78M
    Net margin
    -18.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €4.55B +6.8% €54.32M -106.9%
    €5.12B +12.7% €268.67M +394.6%
    €5.43B +5.9% N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.41
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Jefferson Shreve June 22, 2025 $15.00K–$50.00K
    Jefferson Shreve May 8, 2025 $15.00K–$50.00K
    Julie Johnson March 12, 2025 $1.00K–$15.00K
    Jefferson Shreve March 9, 2025 $15.00K–$50.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 416K $29.96M +355K Buy
    James Anderson 398K $28.64M -1.7M Sell

    Earnings Calls

    Latest earnings call: May 2, 2024 (Q1 2024)

    Add to watchlist

    Notifications